BEVERLY, MA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)EASTERN CARDIOTHORACIC SURGICAL SOCIETY, founded in 1992, is a small nonprofit that reported $417K in total revenue in fiscal year 2023. Revenue surged 21% from the prior year, signaling strong growth momentum. Expenses of $364K left a modest 13% surplus.
TO FOSTER EDUCATION AND THE STUDY OF INTRATHORACIC PHYSIOLOGY, PATHOLOGY AND THERAPY.
ANNUAL MEETING - SEMINARS TO EDUCATE AND STUDY INTRATHORACIC PHYSIOLOGY, PATHOLOGY AND THERAPY.
PUBLICATIONS - INNOVATIONS: TECHNOLOGY AND TECHNIQUES IN CARDIOTHORACIC AND VASCULAR SURGERY IS THE FIRST JOURNAL WHOSE MAIN MISSION IS TO DISSEMINATE INFORMATION SPECIFICALLY ABOUT ADVANCES IN...
PUBLICATIONS - INNOVATIONS: TECHNOLOGY AND TECHNIQUES IN CARDIOTHORACIC AND VASCULAR SURGERY IS THE FIRST JOURNAL WHOSE MAIN MISSION IS TO DISSEMINATE INFORMATION SPECIFICALLY ABOUT ADVANCES IN TECHNOLOGY AND TECHNIQUES THAT LEAD TO LESS INVASIVE TREATMENT OF CARDIOTHORACIC AND VASCULAR DISEASE. IT DELIVERS CUTTING EDGE ORIGINAL RESEARCH, REVIEWS, ESSAYS, CASE REPORTS, AND EDITORIALS FROM THE PIONEERS AND EXPERTS IN THE FIELD OF MINIMALLY INVASIVE CARDIOTHORACIC AND VASCULAR DISEASE, INCLUDING BIOMEDICAL ENGINEERS.
OFFICERS AND COMMITTEES - THE SOCIETY ASSEMBLES COMMITTEES TO HELP ORGANIZE AND OPERATE VARIOUS FUNCTIONS OF THE SOCIETY.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $416,837 | $344,071 | +0.2% |
| Expenses | $363,791 | $369,731 | 0.0% |
| Net Income | $53,046 | $-25,660 | -3.1% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| AFRICA F WALLACE MD | PRESIDENT/VI | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| SPENCER MELBY MD | VICE PRES/TR | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| JOHN LAZAR MD | TREASURER/SE | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| BENJAMIN HAITHCOCK MD | SECRETARY/CO | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| DORAID JARRAR MD | IMMEDIATE PA | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| MUHAMMAD AFTAB MD | PROG CHAIR/C | 1.00 |
Director
|
$0 | $0 | $0 |
| IBRAHIM SULTAN MD | CARDIAC CHIE | 1.00 |
Director
|
$0 | $0 | $0 |
| THOMAS CARANASOS MD | CARDIAC CHIE | 1.00 |
Director
|
$0 | $0 | $0 |
| ROMAN PETROV MD | THORACIC CHI | 1.00 |
Director
|
$0 | $0 | $0 |
| SAI YENDAMURI MD | THORACIC CHI | 1.00 |
Director
|
$0 | $0 | $0 |
| TYLER WALLEN DO | MEM. COMM. C | 1.00 |
Director
|
$0 | $0 | $0 |
| HASSAN KHALIL MD | RES. INN. CO | 1.00 |
Director
|
$0 | $0 | $0 |
| DARRYL WEIMAN MD JD | STD AND ETHI | 1.00 |
Director
|
$0 | $0 | $0 |
| CHARLES BAKHOS MD | CAREER DEV C | 1.00 |
Director
|
$0 | $0 | $0 |
| ANDREA WOLF MD | JUSTICE COMM | 1.00 |
Director
|
$0 | $0 | $0 |
| JULIAN GUITRON MD | SOC. MEDIA C | 1.00 |
Director
|
$0 | $0 | $0 |
| PANOS VARDAS MD | PREPROG CHAI | 1.00 |
Director
|
$0 | $0 | $0 |
| AUNDREA OLIVER MD | COUNCILOR/TH | 1.00 |
Director
|
$0 | $0 | $0 |
| HUZAIFA SHAKIR MD FACS | COUNCILOR/ST | 1.00 |
Director
|
$0 | $0 | $0 |
| KATY A MARINO MD | COUNCILOR-AT | 1.00 |
Director
|
$0 | $0 | $0 |
| AFSHIN EHSAN MD | COUNCILOR-AT | 1.00 |
Director
|
$0 | $0 | $0 |
| SHARON BEN-OR MD | PAST PRESIDE | 1.00 |
Director
|
$0 | $0 | $0 |
| T SLOANE GUY MD MBA | MEM. COM. CH | 1.00 |
Director
|
$0 | $0 | $0 |
| LOUIS STEIN MD PHD | RESEARCH CH. | 1.00 |
Director
|
$0 | $0 | $0 |
| JAMES SPEICHER MD | COUN-AT-LRG | 1.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $416,837 | $363,791 | $369,139 | $53,046 |
| 2022 | $344,071 | $369,731 | $305,519 | $-25,660 |
| 2021 | $314,815 | $263,844 | $356,650 | $50,971 |
| 2019 | $322,274 | $199,096 | $426,014 | $123,178 |
| 2018 | $210,121 | $193,109 | $302,836 | $17,012 |
Compare EASTERN CARDIOTHORACIC SURGICAL SOCIETY with other nonprofits in Massachusetts and across the country.